2017 Aesthetic Extender Symposium
October 12-October 15, 2017
Miami, FL

How to Claim Credit
Take the evaluation and download your CME/CE certificate here: http://akhinc.formstack.com/forms/aes17. For questions related to CME, please contact info@cmepartner.org.

Program Overview
The 2017 Aesthetic Extender Symposium is a three-day symposium that features didactic lectures, interactive question and answer sessions and live demonstrations of the use of injectables, including new products on the market, allowing for a broad overview of products, facial analysis and technique. Specifically, the faculty will review the principles of safe and effective aesthetic treatments for facial rejuvenation that combine neurotoxins, soft tissue fillers with other modalities with advanced techniques for facial enhancement. This symposium will provide attendees with transferable skills and related techniques that can quickly and easily be adapted to their current practice environment.

Target Audience
This symposium is designed for an audience of physicians, physician assistants, nurses and nurse practitioners who work under the direct supervision of dermatologists, facial plastic surgeons, oculoplastic surgeons, and plastic surgeons, and commonly assist with cosmetic surgery and medicine.

Learning Objectives
Upon completion of the educational activity, participants should be able to:

  • Discuss indications, contraindications, and properties of filling agents currently approved for use in the US
  • Compare and contrast treatment approaches for aesthetics patients based on sex, race, age and skin type
  • Appraise injection techniques for specific regions including the aging face, hands and neck
  • Describe the principles of aesthetic treatments that combine neurotoxins and soft tissue fillers with other modalities
  • Analyze available laser and light technologies for facial rejuvenation, skin resurfacing and treatment of scars, acne, and other dermatologic conditions
  • Appraise the latest advanced techniques in lasers, light, microneedling, and radiofrequency devices
  • Compare and contrast the available options for non‐invasive and minimally invasive body contouring including radiofrequency, acoustic wave, ultrasound, laser, and infrared energy
  • Review potential applications for human stem cells and platelet rich plasma
  • Discuss strategies for prevention and treatment of complications from a variety of aesthetic procedures
  • Review the latest developments in injectables
  • Analyze the range of body contouring procedures that can best be applied to an individual patient’s goals
  • Review the best treatment options and prevention methods for biofilms following injectables

Breakout Session:

  • Recognize non-facial areas currently being treated with poly-l-lactic acid in the medical aesthetic community.
  • Discuss components of the currently available formulation of poly-l-lactic acid.
  • Explain currently utilized reconstitutions/dilutions of poly-l-lactic-acid for non-facial uses.
  • Recognize appropriate depth for placement of poly-l-lactic-acid used in non-facial areas.
  • Analyze possible sequelae from treatment with poly-l-lactic-acid in non-facial areas.

Criteria for Success
Statements of credit will be awarded based on the participant's attendance, participation in the pre/post-test and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at http://www.aestheticextendersymposium.com/cme. You must participate in the entire activity to receive credit. There If you have questions about this CME/CE activity, please contact AKH Inc. at tbrignoni@akhcme.com.

AKHCME Credit provided by AKH Inc., Advancing Knowledge in Healthcare

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of AKH Inc., Advancing Knowledge in Healthcare and Aesthetic Extender Symposium. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians. AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 21.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 21.25 Contact Hours.

Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and the Aesthetic Extender Symposium.

Shino Bay Aguilera, DO Consultant Allergan,Inc., Cynosure, Inc., Galderma Laboratories, L.P., Merz Pharma, SkinCeuticals
Royalties Allergan,Inc., Cynosure, Inc., Galderma Laboratories, L.P., Merz Pharma, SkinCeuticals
Speakers Bureau Allergan,Inc., Cynosure, Inc., Galderma Laboratories, L.P., Merz Pharma, SkinCeuticals
Leslie Baumann, MD Stock Skin Type Solutions, Inc.
Michael Gold, MD Advisory Board Aerolase, Almiral, Croma, Erchonia Corporation, Inta Derm, Johnson & Johnson, Prollenium, Sente, Sinclair Pharma, Thermi Aesthetics
Consultant Aerolase, Allergan, Inc, Alma Lasers, Ltd., Almiral, Anacor Pharmaceuticals, Inc., Aquavit Pharm, Bayer Healthcare Pharmaceuticals, Celgene Corporation, Clarsonic, SkinCeuticals, L’Oreal, Croma, DefanAge, DUSA Pharmaceuticals, Inc./Sun Pharma, EndyMed Medical Ltd., Erchonia Corporation, Exeltis, Galderma Laboratories, L.P., Inta Derm, Invasix Ltd., Johnson & Johnson, Lumenis Ltd., Merz Pharma, Neothetics, Novartis, Pierre Fabre, Prollenium, Promius Pharma, LLC., Sente, Sinclair Pharma, Smith & Nephew, Syneron-Candela, Suneva Medical, Inc., Thermi Aesthetics, Valeant Pharmaceuticals International, Inc., Viviscal, Zimmer
Stock Aerolase, DefenAge, Intraderm, Invasix, Sente
David J. Goldberg, MD, JD Consultant RSI, Sensus Healthcare, Stratpharma, Wintech
Contracted Research Allergan, Inc, Cutera, Inc, Cynosure, Inc., Galderma Laboratories, Merz Pharma, Sensus Healthcare, Sienna, Stratpharma
Speakers Bureau Cutera, Inc, Lumenis, Sensus Healthcare, Stratpharma
Stock Aquavit Pharmaceuticals, Inc.
Mary Beth Hagen N/A Nothing to disclose
Krystie P. Lennox, PA-C N/A Nothing to disclose
Bonnie Marting, DNP, ARNP Speakers Bureau Galderma Laboratories
Patti Owens, RN, BSN Consultant Rockwell Laser Industries and Owner of OLTUSA and AesthetMed Consultant International
Honoraria Meeting Design, A+MD
Royalty Malady/Cengage
Tanya Patron, PA-C N/A Nothing to disclose
Marina Peredo, MD N/A Nothing to disclose
Jason Pozner, MD, FACS Advisory Board Allergan,Inc., Canfield Scientific Inc., Cytrellis Biosystems Inc., Merge Healthcare, Merz Pharma, Midmark, NewBeauty®, RealSelf, Syneron, Inc., Valeant Pharmaceuticals North American LLC
Alpha Group Zeltiq Aesthetics Inc.
Board Member Plastic Surgery Channel
Clinical Advisory Panel Mentor Worldwide LLC
Consultant Merz Pharma, Sciton, Inc.
Contracted Research Cytrellis Biosystems Inc, Lutronic Aesthetics, MTF
Discount Alma Lasers, Ltd., BTL, Canfield Scientific, Inc., Cynosure, Inc. /HOYA ConBio, Cytori Therapeutics, Inc., Ellman International, Inc., Invasix Ltd., Jeisys, Ra Medical Systems,
Solta Medical, Inc/Sound Surgical Technologies LLC, Zeltiq Aesthetics Inc.
Editorial Board Journal of Cosmetic & Laser Therapy, Plastic Surgery Education Network, Quality Medical Publishing-Pulse News
Equipment Apollo Laser Skin Treatment, Bella Contour, BTL, Cutera, Cynosure/HOYA ConBio, Exilis, Human Med, Jeisys, Lutronic Aesthetics, Oculo-Plastik, Inc., Sciton, Inc., Serene Medical, Syneron, Inc, Solta Medical, Inc/Sound Surgical Technologies LLC, Thermi, Zimmer
Investigator Cynosure, Inc. /HOYA ConBio, Invasix Ltd, Syneron, Inc.
Reviewer Plastic and Reconstructive Surgery, Prime: International Journal of Aesthetic and Anti-Ageing Medicine
Section Editor Aesthetic Plastic Surgery
Speakers Bureau Alma Lasers, Ltd., Cynosure, Inc., Inmode, Lifecell, Sciton, Solta Medical, Inc/Sound Surgical Technologies LLC, Thermi, Zeltiq Aesthetics Inc.
Stock Cytrellis Biosystems Inc, Inmode, Invasix Ltd., Keller Medical, Inc., Plastic Surgery Channel, RealSelf, Revance Therapeutics Inc., Sciton, Inc., TDM Pharmaceutical Research LLC, Thermi
Charles Runels, MD Royalties Cellular Medicine Group
Cheryl Staurowsky, LE N/A Nothing to disclose
Ilanit Samuels, PA-C, MCM N/A Nothing to disclose
AKH & AES Staff/Planners N/A Nothing to disclose

Commercial Support
This activity is supported by educational grants from Allergan, Inc., Galderma Laboratories, L.P., Merz North America, Inc., and Suneva Medical.
This activity is supported by in-kind support contributions from Aerolase, Allergan, Inc., Eclipse, Galderma Laboratories, L.P., Lutronic, Merz North America, Inc., Sciton.

Disclosure Declaration
It is the policy of AKH Inc. and AES to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH Inc. planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and AES specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.